These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 5381888

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES, Komarova AA.
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP, Agarwala MC, Singh SK.
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA.
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract] [Full Text] [Related]

  • 6. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK, Singh SK.
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract] [Full Text] [Related]

  • 7. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M, Zacara A, Woźniak S.
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S, Nosaki M, Iwasaki M, Hamano S, Furuya Y.
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H, Opl G.
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract] [Full Text] [Related]

  • 17. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 Nov; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 18. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP.
    Probl Tuberk; 1967 Nov; 45(9):21-6. PubMed ID: 4303748
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 20. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV, Parthasarathy R, Sambamoorthy S, Somasundaram PR, Subbammal S.
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.